Evidence map›Paper›PMID 41134837›Full record

ArticlePloS one2025

On utilizing gaze behavior to predict movement transitions during natural human walking on different terrains.

Martina Hasenjäger, Christiane B Wiebel-Herboth

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Martina HasenjägerHonda Research Institute Europe GmbH, Offenbach am Main, Germany.ORCID https://orcid.org/0000-0001-8438-5865
Christiane B Wiebel-HerbothHonda Research Institute Europe GmbH, Offenbach am Main, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human gaze behavior is crucial for successful goal-directed locomotion. In this study we explore the potential of gaze information to improve predictions of walk mode transitions in real-world urban environments which has not been investigated in great detail, yet. Using a dataset with IMU motion data and gaze data from the Pupil Labs Invisible eye tracker, twenty participants completed three laps of an urban walking track with three walk modes: level walking, stairs (up, down), and ramps (up, down). In agreement with previous findings, we found that participants directed their gaze more towards the ground during challenging transitions. They adjusted their gaze behavior up to four steps before adjusting their gait behavior. We trained a random forest classifier to predict walk mode transitions using gaze parameters, gait parameters, and both. Results showed that the more complex transitions involving stairs were easier to predict than transitions involving ramps, and combining gaze and gait parameters provided the most reliable results. Gaze parameters had a greater impact on classification accuracy than gait parameters in most scenarios. Although prediction performance, as measured by Matthews' correlation coefficient (MCC), declined with increasing forecasting horizons (from one to four steps ahead), the model still achieved robust classification performance well above chance level (MCC = 0), with an average MCC of 0.60 when predicting transitions from level walking to stairs (either up or down) four steps in advance. The study suggests that gaze behavior changes in anticipation of walk mode transitions and the expected challenge for balance control, and has the potential to significantly improve the prediction of walk mode transitions in real-world gait behavior.

Indexed as

Eye MovementsFixation, OcularWalkingAdultFemaleGaitHumansMaleYoung Adult

Identifiers

PMID41134837
PMCPMC12551874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.